Document Detail


Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability.
MedLine Citation:
PMID:  16514068     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The transcription factor GATA4 is a critical regulator of cardiac gene expression where it controls embryonic development, cardiomyocyte differentiation, and stress responsiveness of the adult heart. Traditional deletion of Gata4 caused embryonic lethality associated with endoderm defects and cardiac malformations, precluding an analysis of the role of GATA4 in the adult myocardium. To address the function of GATA4 in the adult heart, Gata4-loxP-targeted mice (Gata4fl/fl) were crossed with mice containing a beta-myosin heavy chain (beta-MHC) or alpha-MHC promoter-driven Cre transgene, which produced viable mice that survived into adulthood despite a 95% and 70% loss of GATA4 protein, respectively. However, cardiac-specific deletion of Gata4 resulted in a progressive and dosage-dependent deterioration in cardiac function and dilation in adulthood. Moreover, pressure overload stimulation induced rapid decompensation and heart failure in cardiac-specific Gata4-deleted mice. More provocatively, Gata4-deleted mice were compromised in their ability to hypertrophy following pressure overload or exercise stimulation. Mechanistically, cardiac-specific deletion of Gata4 increased cardiomyocyte TUNEL at baseline in embryos and adults as they aged, as well as dramatically increased TUNEL following pressure overload stimulation. Examination of gene expression profiles in the heart revealed a number of profound alterations in known GATA4-regulated structural genes as well as genes with apoptotic implications. Thus, GATA4 is a necessary regulator of cardiac gene expression, hypertrophy, stress-compensation, and myocyte viability.
Authors:
Toru Oka; Marjorie Maillet; Alistair J Watt; Robert J Schwartz; Bruce J Aronow; Stephen A Duncan; Jeffery D Molkentin
Related Documents :
21366128 - Measurement of intraabdominal pressure in pregnant women at term.
11110768 - Current perspectives on the use of gene therapy for hypertension.
15479618 - Association between the angiotensin-converting enzyme gene insertion/deletion polymorph...
17148238 - Propagule pressure and persistence in experimental populations.
20651928 - Social pressures to drink or drink a little more: the nigerian experience.
2939208 - Effects of ketanserin on ambulatory blood pressure monitoring in patients with essentia...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2006-03-02
Journal Detail:
Title:  Circulation research     Volume:  98     ISSN:  1524-4571     ISO Abbreviation:  Circ. Res.     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-03-31     Completed Date:  2006-04-13     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0047103     Medline TA:  Circ Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  837-45     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, University of Cincinnati, Children's Hospital Medical Center, Ohio 45229-3039, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apoptosis
Atrial Natriuretic Factor / genetics
Cardiomegaly / etiology*
Cell Survival
GATA4 Transcription Factor / genetics,  physiology*
Gene Deletion
Gene Expression Regulation
Mice
Myocardium / metabolism*
Myocytes, Cardiac / physiology*
Myosin Heavy Chains / genetics
Chemical
Reg. No./Substance:
0/GATA4 Transcription Factor; 0/Gata4 protein, mouse; 0/Myosin Heavy Chains; 85637-73-6/Atrial Natriuretic Factor
Comments/Corrections
Comment In:
Circ Res. 2006 Mar 31;98(6):715-6   [PMID:  16574910 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and pero...
Next Document:  Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growt...